Displaying items by tag: Biosciences Research & Commercialization Center
GRAND RAPIDS — Tetra Therapeutics Inc.’s sale to a Japanese pharmaceutical company provides a final pathway toward bringing to market potential new drugs to treat Alzheimer’s disease and a form of autism, as well as generates a handsome return for financial backers.
GRAND RAPIDS — Drug developer Tetra Discovery Partners Inc. plans to launch a clinical trial later this spring on a potential treatment for an autism spectrum disorder.
KALAMAZOO — Armune BioScience Inc.’s sale to Madison, Wis.-based Exact Sciences Corp. reinforces the reality that some West Michigan-based life sciences firms will have to move out of the region to grow.
HOLLAND — With $600,000 in new capital, a West Michigan startup plans to fund an upcoming human clinical trial for its medical device technology.
An experimental drug under development by Tetra Discovery Partners LLC has the potential to treat traumatic brain injury, according to the results of a pre-clinical trial.
A Southwest Michigan biosciences firm plans to use a recent investment to move its cold weather- and drought-resistant seed technology from the research phase into developing new markets.
PORT SHELDON — A biotech startup will use $1 million in capital to pay for preclinical trials on an innovation it has developed for use in orthopedic surgeries.